Direct Epidemio-Statistics helps you screen your study subjects' health indicators in silico for early risk markers, anticipate multifactorial adverse events with risk scoring, prioritize risks, explore your study cohorts more easily and quickly, and monitor your subjects over the long term. Our risk expertise provides the following benefits:
Direct Epidemio-Statistics can characterize your seeds, search for markers associated with adverse events, anticipate these adverse events using risk scoring, prioritize your risks, facilitate the exploration of your test batches, and reduce the negative impact of adverse events. Our risk expertise brings you the following benefits:
